Regional chemotherapy for unresectable primary liver cancer: Results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Chemotherapy, Cancer, Regional Perfusion
  • Liver Neoplasms
  • Magnetic Resonance Imaging

abstract

  • In patients with unresectable primary liver cancer, HAI therapy can be effective and safe. Pretreatment and early post-treatment changes in tumor perfusion characteristics may predict treatment outcome.

publication date

  • September 10, 2009

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2731015

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdp029

PubMed ID

  • 19491285

Additional Document Info

start page

  • 1589

end page

  • 95

volume

  • 20

number

  • 9